{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:18:10Z","timestamp":1789816690332,"version":"4.0.1"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1411.080729","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T22:48:46Z","timestamp":1225925326000},"page":"1700-1706","source":"Crossref","is-referenced-by-count":103,"title":["Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany"],"prefix":"10.3201","volume":"14","author":[{"given":"Barbara","family":"Eker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Muetterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Centis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Schaberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ruesch-Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the German TBNET Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2008,11]]},"reference":[{"key":"key-10.3201\/eid1411.080729-201209281440-R1","unstructured":"World Health Organization. WHO report 2007; global tuberculosis control, surveillance, planning, financing. Geneva: The Organization; 2007."},{"key":"key-10.3201\/eid1411.080729-201209281440-R2","unstructured":"World Health Organization. WHO report 2008; global tuberculosis control, surveillance, planning, financing. Geneva: The Organization; 2008."},{"key":"key-10.3201\/eid1411.080729-201209281440-R3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/505877","article-title":"Global incidence of multidrug-resistant tuberculosis.","volume":"194","author":"Zignol","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R4","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(06)69863-2","article-title":"Epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis.","volume":"368","author":"Aziz","year":"2006","journal-title":"Lancet"},{"key":"key-10.3201\/eid1411.080729-201209281440-R5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1056\/NEJM200104263441706","article-title":"Global trends in resistance to antituberculosis drugs. World Health Organization\u2013International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.","volume":"344","author":"Espinal","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1411.080729-201209281440-R6","first-page":"125","article-title":"WHO launches new Stop TB strategy to fight the global tuberculosis epidemic.","volume":"60","year":"2006","journal-title":"Indian J Med Sci"},{"key":"key-10.3201\/eid1411.080729-201209281440-R7","doi-asserted-by":"crossref","unstructured":"World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: The Organization; 2008.","DOI":"10.1016\/S8756-3452(08)70748-5"},{"key":"key-10.3201\/eid1411.080729-201209281440-R8","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO\/HTM\/TB\/2006.361. Geneva: The Organization; 2006."},{"key":"key-10.3201\/eid1411.080729-201209281440-R9","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2014worldwide, 2000\u20132004.","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1411.080729-201209281440-R10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug-resistant tuberculosis.","volume":"13","author":"Shah","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(05)17786-1","article-title":"Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.","volume":"365","author":"Leimane","year":"2005","journal-title":"Lancet"},{"key":"key-10.3201\/eid1411.080729-201209281440-R12","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"key-10.3201\/eid1411.080729-201209281440-R13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1183\/09031936.00077307","article-title":"Clinical and operational value of the extensively drug-resistant tuberculosis definition.","volume":"30","author":"Migliori","year":"2007","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1411.080729-201209281440-R14","unstructured":"Robert-Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland f\u00fcr 2006. Berlin: The Institute; 2008."},{"key":"key-10.3201\/eid1411.080729-201209281440-R15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1183\/09031936.94.07081545","article-title":"Tuberculosis control in Europe and international migration.","volume":"7","author":"Rieder","year":"1994","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1411.080729-201209281440-R16","first-page":"748","article-title":"Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO\/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994\u20131998.","volume":"6","author":"Laszlo","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R17","first-page":"430","article-title":"Extensively drug-resistant tuberculosis (XDR TB): recommendations for prevention and control.","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid1411.080729-201209281440-R18","first-page":"640","article-title":"Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.","volume":"9","author":"Laserson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R19","unstructured":"Robert-Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland f\u00fcr 2004. Berlin: The Institute; 2006."},{"key":"key-10.3201\/eid1411.080729-201209281440-R20","unstructured":"Robert-Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland f\u00fcr 2005. Berlin: The Institute; 2007."},{"key":"key-10.3201\/eid1411.080729-201209281440-R21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1086\/528875","article-title":"Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.","volume":"46","author":"Migliori","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R22","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/522537","article-title":"Impact of extensive drug resistance on treatment outcomes in non\u2013HIV-infected patients with multidrug-resistant tuberculosis.","volume":"45","author":"Kim","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1183\/09031936.00159807","article-title":"Fluoroquinolones: Are they essential to treat multidrug-resistant tuberculosis?","volume":"31","author":"Migliori","year":"2008","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1411.080729-201209281440-R24","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1183\/09031936.00028708","article-title":"Does resistance to second-line injectables lead to worse treatment outcomes in MDR and XDR TB?","volume":"31","author":"Migliori","year":"2008","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1411.080729-201209281440-R25","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3201\/eid1305.070200","article-title":"Extensively drug-resistant tuberculosis, Italy and Germany.","volume":"13","author":"Migliori","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1086\/509328","article-title":"Patients with previously treated tuberculosis no longer neglected.","volume":"44","author":"Zignol","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R27","first-page":"887","article-title":"Determinants of drug-resistant tuberculosis: analysis of 11 countries.","volume":"5","author":"Espinal","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis.","volume":"56","author":"Fortun","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1411.080729-201209281440-R29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1128\/AAC.47.1.416-417.2003","article-title":"In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs.","volume":"47","author":"Alcal\u00e1","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1411.080729-201209281440-R30","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(01)06964-1","article-title":"Oxazolidinone antibiotics.","volume":"358","author":"Diekema","year":"2001","journal-title":"Lancet"},{"key":"key-10.3201\/eid1411.080729-201209281440-R31","first-page":"275","article-title":"In vitro efficacy of linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.","volume":"29","author":"Molicotti","year":"2006","journal-title":"New Microbiol"},{"key":"key-10.3201\/eid1411.080729-201209281440-R32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijantimicag.2006.02.011","article-title":"In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates.","volume":"28","author":"Tato","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid1411.080729-201209281440-R33","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1086\/322523","article-title":"Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.","volume":"33","author":"Brown-Elliott","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2133.2004.06230.x","article-title":"Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.","volume":"151","author":"Kyle","year":"2004","journal-title":"Br J Dermatol"},{"key":"key-10.3201\/eid1411.080729-201209281440-R35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/jinf.2002.0970","article-title":"Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.","volume":"44","author":"Nannini","year":"2002","journal-title":"J Infect"},{"key":"key-10.3201\/eid1411.080729-201209281440-R36","first-page":"345","article-title":"Linezolid in the treatment of \u201cdifficult\u201d multidrug-resistant tuberculosis.","volume":"12","author":"Yew","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jinf.2005.04.007","article-title":"Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR TB)\u2014a report of ten cases.","volume":"52","author":"von der Lippe","year":"2006","journal-title":"J Infect"},{"key":"key-10.3201\/eid1411.080729-201209281440-R38","first-page":"606","article-title":"Linezolid for the treatment of patients with atypical mycobacterial infections: a systematic review.","volume":"11","author":"Ntziora","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid1411.080729-201209281440-R39","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1128\/AAC.01113-06","article-title":"First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.","volume":"51","author":"Richter","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1411.080729-201209281440-R40","doi-asserted-by":"publisher","first-page":"e1126","DOI":"10.1371\/journal.pone.0001126","article-title":"Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR TB among treatment failures.","volume":"2","author":"Cox","year":"2007","journal-title":"PLoS One"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/14\/11\/08-0729_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:30:38Z","timestamp":1732631438000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/14\/11\/08-0729_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1411.080729","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}